- John Jumper, who shared the 2024 Nobel Prize in Chemistry for AlphaFold, is leaving Google DeepMind after nearly nine years to join rival Anthropic.
- Jumper announced the move on X on June 19, 2026, and said he would take time to recharge before starting at the AI lab; neither side has disclosed his future role.
- The hire follows Anthropic’s $400 million stock acquisition of stealth biotech Coefficient Bio in April 2026, signaling a deeper push into life sciences.
- His exit landed one day after Gemini co-lead Noam Shazeer announced he was leaving DeepMind for OpenAI.
What Happened
John Jumper, the Google DeepMind vice president who shared the 2024 Nobel Prize in Chemistry for creating the protein-structure system AlphaFold, is leaving the company to join competitor Anthropic. Jumper confirmed the departure in a post on X on Thursday, June 19, 2026, after what he described as “nearly 9 years” at the lab, TechCrunch reported. He said he would take time to recharge before starting at Anthropic, and neither he nor the company has disclosed what role he will take.
In his message, Jumper credited DeepMind CEO Demis Hassabis, with whom he shared the Nobel, for the opportunity that defined his career. “Demis Hassabis took a real chance letting me lead the AlphaFold team just six months after finishing my PhD, and the entire GDM team taught me so much about how to do great science,” he wrote. He added, “GDM is a special place, and I’ll still be excited to hear about what amazing things they discover next.”
Why It Matters
The move is one of the most prominent talent transfers between leading AI labs to date, taking a Nobel-decorated scientist from Google’s research arm to its fastest-growing rival. Jumper is not a generalist engineer but the figure most associated with AI’s clearest scientific breakthrough, which makes his choice of destination a signal about where he believes the next wave of applied research will happen. For Anthropic, best known for its Claude models, recruiting him strengthens a credibility case in computational biology that it has been building through acquisitions and hiring. The company has been expanding rapidly on the back of a reported $965 billion valuation, detailed in our coverage of Anthropic’s valuation, and is converting that capital into specialized talent.
Technical Details
Jumper led the team behind AlphaFold2, the system that made accurate protein-structure prediction practical at scale. According to reporting, AlphaFold has been used by more than two million scientists across 190 countries since its release, and DeepMind’s associated database published predicted structures for roughly 200 million proteins, work that compressed problems once measured in years into hours. That track record is the asset Anthropic is acquiring. The lab’s biology ambitions became concrete in April 2026, when it paid $400 million in stock for Coefficient Bio, a stealth biotech startup with fewer than 10 employees, many of them former Genentech computational-biology researchers. That division is led by Eric Kauderer-Abrams, and Jumper’s arrival would add a globally recognized name to a unit that is still small relative to Anthropic’s headline model work.
Who’s Affected
The departure stings DeepMind most directly, coming amid a broader outflow of researchers. Jumper’s exit landed one day after Noam Shazeer, a co-author of the original transformer paper and a Gemini co-lead, announced he was leaving DeepMind for OpenAI, putting two landmark losses inside roughly 48 hours. Reporting cited by The Next Web described engineers moving from DeepMind to Anthropic at an approximately 11-to-1 ratio, a lopsided flow that points to a wider retention problem. Anthropic benefits as the receiving lab, while the scientific community that depends on AlphaFold gains little clarity in the near term, since Jumper has not said whether his new work will continue along protein-structure lines or branch into other areas of biology. The episode also unfolds against a tense regulatory backdrop for Anthropic, which recently faced a US export order, as covered in our report on the order forcing Anthropic to pull models worldwide.
What’s Next
The immediate open question is what Jumper will actually build at Anthropic, and the company has not committed to a public answer. His hire fits a pattern in which Anthropic pairs frontier language models with domain science, an approach that overlaps with health and biology initiatives like its Gates Foundation partnership. Whether that produces a dedicated AlphaFold-style program or feeds biology capabilities into Claude is unconfirmed. For DeepMind, the test is whether it can stem departures of senior researchers after two high-profile exits in two days. Jumper said he plans to rest before starting, so any concrete output from the move is unlikely to surface for months, and the labs themselves will decide how much of the work becomes public.
